Sagefield Capital’s Inozyme Pharma INZY Stock Holding History

Sagefield Capital’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-24,673	Closed	-$98.7K	–	125
2025 Q2	$98.7K	Buy	+24,673	New	+$61.1K	0.01%	90

Sagefield Capital's INZY Position: Q3 2025 in Review

Sagefield Capital sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 24,673 shares — an estimated $98.7K sold.

Sagefield Capital first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $98.7K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Sagefield Capital reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Sagefield Capital sold 24,673 Inozyme Pharma shares in Q3 2025, an estimated $98.7K.
Sagefield Capital first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
Sagefield Capital's Inozyme Pharma position peaked at $98.7K in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Sagefield Capital's 13F filing for Q3 2025, filed 14 Nov 2025.